(07-10-2014 11:39 AM)DVY Wrote: I just purchased shares and options (0.99c at strike price 3.0 dollars- feb 2015) of Veringo (VRNG).
Okay, i will read up on it. Let me elaborate why i had that negative first impression.
It is a technology patent troll company. It is not a bio-pharmaceutical company or a biotech company. Why is this relevant? Bear with me here. We are both familiar with the biological sciences, so we both know how hard it is to bypass patent protection in biotech areas, especially with Orphan Drug status.
This difficulty doesnt exist in technology areas.There is no "Orphan Tech Status" in technology space. VRNG business model may make sense in biotech space, but not in technology space.
There are tens of hundreds of tech companies worth millions(with patents and lawyers) that became obsolete because some child in a garage invented a new software that out-compete their tech( which undergirds their business model).
So, VRNG won a tech patent infringement here and there, and never loses... so what?. how much is that patent worth in the open market giving the plethora of new tech coming in every month, doing old things better? As such, grabbing tech patents is like going for sloppy seconds, actually, sloppy thirds or sixth on a porn set after a gangbang.
I would rather look into buying the stocks of a company X producing new tech X that kicks arse; than a company Z suing company X for tech X... by the time company Z gets his hands on tech X, company X has moved on to tech Y or even worse, reverse engineer a better version of tech X and launch it. To further make my point, GOOG and MSFT have been sued several times...even entire countries has sued them. Look at the stocks of GOOG and MSFT versus the stock of the companies that have sued them? Which one perform better? I think you know the answer to that.(I have attached below the stock charts of VRNG versus GOOG and MSFT. to give a good comparison)
From the little i understand about the technology space, you need three things to have competitive advantage. (1) first to market (2)ability to out-execute the competition (3)hot-pace innovation within your company. otherwise, you will simply die out.
This is not biotech where i can see this business model working because of the strong patent protection clauses in that industry. also, because in the biotech, a patent is worth millions or billions for a decade or far more. So, if you get your hands on a biotech patent, you can be set for over a decade. This is not the case in technology space. New things become obsolete overnight. It is hard to reverse engineer in biotech, however, in tech space, you can reverse engineer EVERY BLOODY THING....and make it better.
This is why i think option trading is the best way to go about VRNG.. it is either a hero... or a zero.
anyways, later, i will read the financials on the company.
regards,
Nemencine.
I did
only 44.5% last year... clearly, you kicked my arse. good work.
p.s.s. I have attached below the stock chart of VRNG since 2010 for the last couple of years...I could only go far back to 2010; and compare it to the stocks of GOOG and MSFT from the same period(2010)